Brown Vance R
SEC CIK 1868243 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | SVP, GC, Corp. Sec | 52.3K | — | $5.26M | 50 | 2021-10-02 | 2026-02-13 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
| 13 | Brown Vance R | EVP, GC, Corp. Sec | — | — |
Transactions 50
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Brown Vance R | EVP, GC, Corp. Sec | F - Tax | $74.73 | -14.6K | 52.3K | -22% | -$1.09M |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Brown Vance R | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,808 | 65.1K | +8% | $0 |
| DM | 2026-02-18 | 2026-02-13 | BSX | Boston Scientific | Brown Vance R | EVP, GC, Corp. Sec | A - Grant | $0.00 | +29.6K | 64.0K | +86% | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Brown Vance R | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,442 | 34.9K | +4% | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Brown Vance R | EVP, GC, Corp. Sec | F - Tax | $74.12 | -488 | 34.4K | -1% | -$36.2K |
| D | 2025-07-02 | 2025-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,036 | 35.4K | +13% | $0 |
| D | 2025-07-02 | 2025-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $104.78 | -1,952 | 33.5K | -6% | -$204.5K |
| 2025-05-22 | 2025-05-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $106.42 | -4,826 | 31.4K | -13% | -$513.6K | |
| 2025-04-22 | 2025-04-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $95.09 | -4,826 | 36.2K | -12% | -$458.9K | |
| 2025-03-24 | 2025-03-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $100.85 | -4,826 | 41.0K | -11% | -$486.7K | |
| 2025-02-21 | 2025-02-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $104.64 | -4,826 | 45.8K | -10% | -$505.0K | |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,689 | 51.2K | +10% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $106.11 | -2,269 | 50.7K | -4% | -$240.8K |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,442 | 48.7K | +3% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $105.77 | -424 | 48.3K | -0.9% | -$44.8K |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | A - Grant | $0.00 | +14.7K | 53.6K | +38% | $0 | |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $105.98 | -6,350 | 47.2K | -12% | -$673.0K | |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +6,456 | 40.9K | +19% | $0 |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $89.32 | -1,991 | 38.9K | -5% | -$177.8K |
| D | 2024-07-02 | 2024-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,036 | 36.4K | +12% | $0 |
| D | 2024-07-02 | 2024-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $76.41 | -1,952 | 34.4K | -5% | -$149.2K |
| DM | 2024-05-23 | 2024-05-21+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | S - Sale+OE | $75.79 | -33.0K | 32.3K | -51% | -$2.50M |
| DM | 2024-05-23 | 2024-05-21+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $25.70 | +33.0K | 50.4K | +191% | +$849.3K |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +3,579 | 32.1K | +13% | $0 |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $65.82 | -1,052 | 31.1K | -3% | -$69.2K |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,850 | 30.4K | +6% | $0 |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $65.95 | -629 | 29.8K | -2% | -$41.5K |
| 2023-08-28 | 2023-08-25 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | S - Sale | $50.52 | -15.8K | 28.6K | -36% | -$795.7K | |
| D | 2023-07-03 | 2023-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,036 | 45.7K | +10% | $0 |
| D | 2023-07-03 | 2023-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $54.09 | -1,359 | 44.3K | -3% | -$73.5K |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +779 | 41.9K | +2% | $0 |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $46.23 | -229 | 41.7K | -0.5% | -$10.6K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +3,579 | 40.4K | +10% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $46.51 | -1,080 | 39.9K | -3% | -$50.2K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $47.29 | -323 | 38.6K | -0.8% | -$15.3K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +923 | 38.9K | +2% | $0 |
| D | 2022-10-04 | 2022-10-02 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +3,394 | 39.0K | +10% | $0 |
| D | 2022-10-04 | 2022-10-02 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $38.73 | -997 | 38.0K | -3% | -$38.6K |
| D | 2022-07-06 | 2022-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +4,035 | 36.8K | +12% | $0 |
| D | 2022-07-06 | 2022-07-01 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $38.01 | -1,185 | 35.6K | -3% | -$45.0K |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $44.17 | -300 | 32.8K | -0.9% | -$13.3K |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,019 | 33.1K | +3% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $42.55 | -230 | 32.0K | -0.7% | -$9,786 |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +779 | 32.3K | +2% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,741 | 31.7K | +6% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $42.72 | -546 | 31.5K | -2% | -$23.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +923 | 30.6K | +3% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $44.01 | -323 | 30.3K | -1% | -$14.2K |
| D | 2021-10-04 | 2021-10-02 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +3,393 | 30.8K | +12% | $0 |
| D | 2021-10-04 | 2021-10-02 | BSX | Boston Scientific | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $43.80 | -1,137 | 29.7K | -4% | -$49.8K |
Purchase Sale Sale after option exercise All abbreviations